
Freddie Kirkland Iii
Examiner (ID: 290)
| Most Active Art Unit | 2855 |
| Art Unit(s) | 2855, 2856 |
| Total Applications | 1942 |
| Issued Applications | 1671 |
| Pending Applications | 84 |
| Abandoned Applications | 212 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17775109
[patent_doc_number] => 20220241458
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-04
[patent_title] => Removable Film-Forming Gel Compositions Featuring Adhesion Promoters
[patent_app_type] => utility
[patent_app_number] => 17/612132
[patent_app_country] => US
[patent_app_date] => 2020-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19687
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17612132
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/612132 | Removable Film-Forming Gel Compositions Featuring Adhesion Promoters | May 28, 2020 | Pending |
Array
(
[id] => 16310750
[patent_doc_number] => 20200289488
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-17
[patent_title] => TRANSDERMAL ADMINISTRATION OF FENTANYL AND ANALOGS THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/885429
[patent_app_country] => US
[patent_app_date] => 2020-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10601
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16885429
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/885429 | TRANSDERMAL ADMINISTRATION OF FENTANYL AND ANALOGS THEREOF | May 27, 2020 | Abandoned |
Array
(
[id] => 17480438
[patent_doc_number] => 20220087942
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-24
[patent_title] => ENTERIC TABLET CONTAINING DIMETHYL FUMARATE
[patent_app_type] => utility
[patent_app_number] => 17/441256
[patent_app_country] => US
[patent_app_date] => 2020-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9007
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17441256
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/441256 | ENTERIC TABLET CONTAINING DIMETHYL FUMARATE | May 20, 2020 | Abandoned |
Array
(
[id] => 16504701
[patent_doc_number] => 20200383957
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-10
[patent_title] => DEPOT FORMULATIONS
[patent_app_type] => utility
[patent_app_number] => 16/877957
[patent_app_country] => US
[patent_app_date] => 2020-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37678
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16877957
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/877957 | DEPOT FORMULATIONS | May 18, 2020 | Abandoned |
Array
(
[id] => 17312700
[patent_doc_number] => 20210401748
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-30
[patent_title] => Powder for oral suspension containing lamotrigine
[patent_app_type] => utility
[patent_app_number] => 16/974343
[patent_app_country] => US
[patent_app_date] => 2020-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5926
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16974343
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/974343 | Powder for oral suspension containing lamotrigine | May 17, 2020 | Abandoned |
Array
(
[id] => 17176826
[patent_doc_number] => 11154053
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-10-26
[patent_title] => Compositions for controlling phytoplankton contamination
[patent_app_type] => utility
[patent_app_number] => 15/930141
[patent_app_country] => US
[patent_app_date] => 2020-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 35
[patent_no_of_words] => 20302
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 174
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15930141
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/930141 | Compositions for controlling phytoplankton contamination | May 11, 2020 | Issued |
Array
(
[id] => 17176826
[patent_doc_number] => 11154053
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-10-26
[patent_title] => Compositions for controlling phytoplankton contamination
[patent_app_type] => utility
[patent_app_number] => 15/930141
[patent_app_country] => US
[patent_app_date] => 2020-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 35
[patent_no_of_words] => 20302
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 174
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15930141
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/930141 | Compositions for controlling phytoplankton contamination | May 11, 2020 | Issued |
Array
(
[id] => 17176826
[patent_doc_number] => 11154053
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-10-26
[patent_title] => Compositions for controlling phytoplankton contamination
[patent_app_type] => utility
[patent_app_number] => 15/930141
[patent_app_country] => US
[patent_app_date] => 2020-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 35
[patent_no_of_words] => 20302
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 174
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15930141
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/930141 | Compositions for controlling phytoplankton contamination | May 11, 2020 | Issued |
Array
(
[id] => 17176826
[patent_doc_number] => 11154053
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-10-26
[patent_title] => Compositions for controlling phytoplankton contamination
[patent_app_type] => utility
[patent_app_number] => 15/930141
[patent_app_country] => US
[patent_app_date] => 2020-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 35
[patent_no_of_words] => 20302
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 174
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15930141
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/930141 | Compositions for controlling phytoplankton contamination | May 11, 2020 | Issued |
Array
(
[id] => 16511587
[patent_doc_number] => 20200390844
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-17
[patent_title] => PAIN RELIEVING SYSTEM
[patent_app_type] => utility
[patent_app_number] => 16/863868
[patent_app_country] => US
[patent_app_date] => 2020-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16389
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16863868
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/863868 | PAIN RELIEVING SYSTEM | Apr 29, 2020 | Abandoned |
Array
(
[id] => 16236653
[patent_doc_number] => 20200253887
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-13
[patent_title] => Composition for the Transdermal Delivery of Fentanyl
[patent_app_type] => utility
[patent_app_number] => 16/861872
[patent_app_country] => US
[patent_app_date] => 2020-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12315
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16861872
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/861872 | Composition for the Transdermal Delivery of Fentanyl | Apr 28, 2020 | Abandoned |
Array
(
[id] => 16511533
[patent_doc_number] => 20200390790
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-17
[patent_title] => PAIN RELIEVER COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 16/862469
[patent_app_country] => US
[patent_app_date] => 2020-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12169
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16862469
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/862469 | PAIN RELIEVER COMPOSITION | Apr 28, 2020 | Abandoned |
Array
(
[id] => 16435527
[patent_doc_number] => 20200352852
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-12
[patent_title] => DEPOT FORMULATIONS
[patent_app_type] => utility
[patent_app_number] => 16/859443
[patent_app_country] => US
[patent_app_date] => 2020-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30518
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16859443
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/859443 | DEPOT FORMULATIONS | Apr 26, 2020 | Abandoned |
Array
(
[id] => 16397154
[patent_doc_number] => 20200338012
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-29
[patent_title] => APIXABAN TRANSDERMAL DELIVERY SYSTEM AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/857304
[patent_app_country] => US
[patent_app_date] => 2020-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26369
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 1
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16857304
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/857304 | APIXABAN TRANSDERMAL DELIVERY SYSTEM AND USES THEREOF | Apr 23, 2020 | Abandoned |
Array
(
[id] => 17774869
[patent_doc_number] => 20220241218
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-04
[patent_title] => TRANSDERMAL THERAPEUTIC SYSTEM
[patent_app_type] => utility
[patent_app_number] => 17/603885
[patent_app_country] => US
[patent_app_date] => 2020-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6373
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17603885
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/603885 | TRANSDERMAL THERAPEUTIC SYSTEM | Apr 16, 2020 | Abandoned |
Array
(
[id] => 16359176
[patent_doc_number] => 20200315927
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-08
[patent_title] => SOLID COSMETIC COMPOSITION FOR EYE MAKE-UP INCLUDING FIBER
[patent_app_type] => utility
[patent_app_number] => 16/837621
[patent_app_country] => US
[patent_app_date] => 2020-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3088
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16837621
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/837621 | SOLID COSMETIC COMPOSITION FOR EYE MAKE-UP INCLUDING FIBER | Mar 31, 2020 | Abandoned |
Array
(
[id] => 16296248
[patent_doc_number] => 20200281971
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-10
[patent_title] => INHIBITING VIRAL AND BACTERIAL ACTIVITY USING LOW CONCENTRATION HYPOCHLOROUS ACID SOLUTIONS
[patent_app_type] => utility
[patent_app_number] => 16/833209
[patent_app_country] => US
[patent_app_date] => 2020-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5359
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16833209
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/833209 | INHIBITING VIRAL AND BACTERIAL ACTIVITY USING LOW CONCENTRATION HYPOCHLOROUS ACID SOLUTIONS | Mar 26, 2020 | Abandoned |
Array
(
[id] => 16511552
[patent_doc_number] => 20200390809
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-17
[patent_title] => GUT-SELECTIVE SEQUESTERING AGENTS FOR THE TREATMENT AND PREVENTION OF AUTISM AND RELATED DISORDERS
[patent_app_type] => utility
[patent_app_number] => 16/827629
[patent_app_country] => US
[patent_app_date] => 2020-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22634
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16827629
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/827629 | GUT-SELECTIVE SEQUESTERING AGENTS FOR THE TREATMENT AND PREVENTION OF AUTISM AND RELATED DISORDERS | Mar 22, 2020 | Abandoned |
Array
(
[id] => 16686463
[patent_doc_number] => 20210068938
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-11
[patent_title] => MULTIPURPOSE IMPLANT WITH MODELED SURFACE STRUCTURE
[patent_app_type] => utility
[patent_app_number] => 16/820692
[patent_app_country] => US
[patent_app_date] => 2020-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10021
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 116
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16820692
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/820692 | MULTIPURPOSE IMPLANT WITH MODELED SURFACE STRUCTURE | Mar 15, 2020 | Abandoned |
Array
(
[id] => 16361533
[patent_doc_number] => 20200318284
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-08
[patent_title] => Laundry Additive for Providing Antimicrobial Effects to Fabrics and Interior Surfaces of Washing Machines
[patent_app_type] => utility
[patent_app_number] => 16/808117
[patent_app_country] => US
[patent_app_date] => 2020-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28417
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16808117
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/808117 | Laundry Additive for Providing Antimicrobial Effects to Fabrics and Interior Surfaces of Washing Machines | Mar 2, 2020 | Abandoned |